Home›Stock Screener›Parnax Lab

Parnax Lab Share Price Today | Stock Price & Parnax Lab Share Screener

PARNAXLAB Pharmaceuticals
Live Share Price NSE
₹113.23
▲ 0.09 (0.08%)
2026-10-05 00:00:00
Live Share Price BSE
₹115.00
▲ 0.00 (0.00%)
2026-10-05 00:00:00

As of October 5, 2026, the live Parnax Lab share price (NSE: PARNAXLAB) is ₹113.23 on NSE and ₹115.00 on BSE, up 0.08% from the previous close, with shares trading between ₹111.12 and ₹117.90 in today's trading session, and a 52-week range of ₹111.73–₹140.78. Check PARNAXLAB yearly price range for the annual price range and momentum. Use the Parnax Lab stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Parnax Lab opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Parnax Lab Market Cap ₹129.95 Cr.
PARNAXLAB P/E Ratio (TTM) 14.31
Parnax Lab P/B Ratio 1.35
EPS (TTM) ₹10.27
Dividend Yield -
Debt to Equity 0.97
PARNAXLAB 52 Week High ₹140.78
Parnax Lab 52 Week Low ₹111.73
Operating Margin 8.00%
Profit Margin -
PARNAXLAB Revenue (TTM) ₹57.00
EBITDA ₹4.00
Net Income -
Total Assets ₹228.00
Total Equity ₹95.00

Parnax Lab Share Price Chart

Track the current stock price of Parnax Lab with an interactive chart. Analyse PARNAXLAB share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Parnax Lab stock quote in one place.

The quote of ₹113.23 sits between the 52-week low of ₹111.73 and the 52-week high of ₹140.78, and the latest session moved 0.08% from the previous close.

Parnax Lab Company Profile - Fundamental Screener

Screen Parnax Lab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for PARNAXLAB shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE383L01019.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE383L01019

Parnax Lab Balance Sheet Screener

Screen PARNAXLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹228, up from ₹190 in 2025.

Latest statistics put total assets at ₹228 and shareholder funds at ₹95, with a leverage ratio of 0.97.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 228 190 190 145 154 106 107 95 87 86
Current Assets 91 65 73 57 71 39 46 37 37 31
Fixed Assets 126 88 90 77 72 60 58 51 44 47

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 37 32 35 20 24 19 22 23 18 18
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 95 83 72 62 48 33 33 36 33 31
Share Capital 12 12 12 12 10 9 9 9 9 9
Reserves & Surplus 84 72 60 51 37 24 24 27 24 23

Parnax Lab Income Statement Screener - Profit & Revenue Analysis

Screen Parnax Lab income statement and profit fundamentals. Analyze PARNAXLAB quarterly results. Parnax Lab reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹57 and net profit was ₹0, equal to earnings per unit of ₹0.37, at an operating margin of 8%.

In that period expenses were ₹53, interest cost ₹2 and tax ₹0. The next period listed, 2026-Mar, shows revenue of ₹72 and net profit of ₹2.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Dec

Revenue and Expenses

Revenue 57 72 64 63 54 50 40 49 50 47 51 43 49 41 47
Expenses 53 65 57 55 46 42 36 41 42 41 45 37 42 36 40

Operating Costs and Margins

EBITDA 4 7 7 9 8 7 5 8 9 6 6 6 7 5 7
Operating Profit % 8.00% 7.00% 9.00% 13.00% 14.00% 14.00% 11.00% 15.00% 17.00% 13.00% 12.00% 12.00% 13.00% 12.00% 16.00%
Depreciation 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2
Interest 2 2 2 1 1 1 1 1 2 1 1 1 1 1 1

Profit and Earnings

Profit Before Tax 1 3 3 5 5 4 2 5 5 3 3 2 4 2 4
Tax 0 1 1 2 1 1 0 2 1 1 1 1 1 1 1
Net Profit 0 2 3 4 3 3 1 3 4 2 2 2 3 1 3
EPS 0.37 1.90 2.37 3.15 2.85 2.55 1.06 2.97 3.47 1.95 1.90 1.63 2.90 1.30 2.96

Parnax Lab Cash Flow Screener - Liquidity Fundamentals

Screen PARNAXLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹32.

Over the same period, investing activities used ₹16 and financing activities used ₹16.

Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March

Cash from Operations and Investing

Operating Activities 32 16 21 9 6 9 9 13 16 4
Investing Activities -16 -32 -10 -17 -7 -13 -11 -5 -10 -6

Financing and Net Cash

Financing Activities -16 15 -14 12 0 5 1 -7 -5 1
Net Cash Flow 0 -1 -3 4 0 0 -1 1 0 -2

Parnax Lab Shareholding Pattern Screener

See Parnax Lab shareholding pattern with promoter, FII, and DII holdings. Check Parnax Lab promoter holding and ownership changes for PARNAXLAB on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 72.30%, foreign institutions 0.00%, domestic institutions 0.00% and the public 22.71%, spread across 3,572 shareholders.

The shareholder count was 3,572 in 2026-Jun, compared with 3,721 in 2026-Mar.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept

Promoter Holding

Promoter Holding 72.30% 72.30% 72.30% 72.30% 72.30% 72.30% 72.30% 72.30%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 22.71% 23.27% 24.37% 24.93% 24.97% 24.73% 24.68% 24.26%
Other Holding 5.00% 4.44% 3.33% 2.77% 2.74% 2.97% 3.02% 3.44%
Shareholder Count 3,572 3,721 3,900 4,111 4,317 4,440 4,521 4,173

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Parnax Lab. Parnax Lab dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Parnax Lab.

Parnax Lab Stock Index Membership - Nifty & Sensex

See which indices include Parnax Lab stock. Check PARNAXLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Parnax Lab is not part of any tracked indices.
Only major market indices are tracked in our system.

Parnax Lab Market Events Screener - Corporate Actions

Get Parnax Lab corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Parnax Lab stock events that may affect PARNAXLAB share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.

It is followed by Quarterly Result Announcement dated August 26, 2026 and Quarterly Result Announcement dated August 14, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-29 2026-09-29 Annual General Meeting NA -11.13%
2026-08-26 2026-08-26 Quarterly Result Announcement NA 0.00%
2026-08-14 2026-08-14 Quarterly Result Announcement NA -0.37%
2026-05-28 2026-05-28 Quarterly Result Announcement NA -0.88%
2026-02-13 2026-02-13 Quarterly Result Announcement NA 1.50%
2025-11-14 2025-11-14 Quarterly Result Announcement NA 0.58%
2025-09-29 2025-09-29 Annual General Meeting NA 2.57%
2025-08-13 2025-08-13 Quarterly Result Announcement NA -2.47%
2025-05-27 2025-05-27 Quarterly Result Announcement NA -4.44%
2025-02-10 2025-02-10 Quarterly Result Announcement NA 2.05%
2024-11-14 2024-11-14 Quarterly Result Announcement NA 0.33%
2024-09-27 2024-09-27 Annual General Meeting NA 1.00%

Parnax Lab Competitors Screener - Peer Stocks Comparison

Screen PARNAXLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 432,120 36.04 61,674 12.69% 11,565 36.68
Divis Laboratories 245,532 84.24 11,067 13.95% 2,568 51.70
Torrent Pharmaceuticals 181,333 84.71 13,886 20.34% 2,138 41.12
Zydus Life Science 114,284 25.27 27,658 17.64% 5,026 47.64
Cipla 108,576 32.50 29,045 2.24% 3,870 34.78
Laurus Labs 107,198 98.20 6,868 22.01% 890 58.70
Mankind Pharma 104,707 50.04 14,636 14.85% 1,938 61.75
Dr Reddys Laboratories 100,679 32.41 35,059 3.90% 4,158 53.84
Aurobindo Pharma 96,479 25.84 34,145 5.56% 3,503 50.30
Lupin 92,885 16.82 29,039 26.75% 5,356 31.59

Parnax Lab Company Announcements - News & Reports Screener

Screen PARNAXLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 3, 2026.

The next most recent announcements are dated October 2, 2026 and October 2, 2026.

Date Update Actions
2026-10-03 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-10-02 Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s -
2026-10-02 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-10-01 Closure of Trading Window -
2026-09-07 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-07 Notice Of 44Th AGM Of The Company -
2026-09-07 Reg. 34 (1) Annual Report. -
2026-08-26 Notice Of Book Closure -
2026-08-26 Board Meeting Outcome for Outcome Of BM Held Today I.E. 26Th August 2026 -
2026-08-14 Financials Results For The Quarter And Three Months Ended June 2026. -
2026-08-14 Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s -
2026-08-14 Board Meeting Outcome for Board Meeting Outcome -
2026-08-14 Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011 -
2026-08-14 Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011 -
2026-08-14 Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011 -
2026-08-14 Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011 -
2026-08-10 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2026-08-10 Announcement under Regulation 30 (LODR)-Change in Management -
2026-08-10 Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot -
2026-08-05 Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Un-Audited IND- AS Compliant Financial Results Along With Limited Review Report For The Quarter (Q1) And Year Ended 30Th June 2026. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹113.23, within a 52-week range of ₹111.73 to ₹140.78. The P/E ratio is 14.31 and the P/B ratio is 1.35, with earnings per unit of ₹10.27. Market capitalisation stands at ₹129.95 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.